about
A role of fukutin, a gene responsible for Fukuyama type congenital muscular dystrophy, in cancer cells: a possible role to suppress cell proliferationNovel Nuclear Protein Complexes of Dystrophin 71 Isoforms in Rat Cultured Hippocampal GABAergic and Glutamatergic NeuronsDystroglycan versatility in cell adhesion: a tale of multiple motifs.A putative Src homology 3 domain binding motif but not the C-terminal dystrophin WW domain binding motif is required for dystroglycan function in cellular polarity in Drosophila.Dynamic formation of microenvironments at the myotendinous junction correlates with muscle fiber morphogenesis in zebrafish.Duplication of the dystroglycan gene in most branches of teleost fish.Altered expression of natively glycosylated alpha dystroglycan in pediatric solid tumors.DNA damage, somatic aneuploidy, and malignant sarcoma susceptibility in muscular dystrophies.High throughput screening for compounds that alter muscle cell glycosylation identifies new role for N-glycans in regulating sarcolemmal protein abundance and laminin bindingDystroglycan does not contribute significantly to kidney development or function, in health or after injury.Increased expression of CD133 and reduced dystroglycan expression are strong predictors of poor outcome in colon cancer patients.VHL-dependent regulation of a β-dystroglycan glycoform and glycogene expression in renal cancerPerlecan and Dystroglycan act at the basal side of the Drosophila follicular epithelium to maintain epithelial organization.Knock-in of Cx46 partially rescues fiber defects in lenses lacking Cx50Biological role of dystroglycan in Schwann cell function and its implications in peripheral nervous system diseases.Disruption of sarcolemmal dystrophin and beta-dystroglycan may be a potential mechanism for myocardial dysfunction in severe sepsis.The evolution of the dystroglycan complex, a major mediator of muscle integrity.Dystroglycan patterns on the prostate of non-obese diabetic mice submitted to glycaemic control.Differential expression of perlecan receptors, α-dystroglycan and integrin β1, before and after invasion of oral squamous cell carcinoma.Mice lacking dystrophin or alpha sarcoglycan spontaneously develop embryonal rhabdomyosarcoma with cancer-associated p53 mutations and alternatively spliced or mutant Mdm2 transcripts.Proliferative, structural and molecular features of the Mdx mouse prostate.Identification of Sp1 and GC-boxes as transcriptional regulators of mouse Dag1 gene promoter.Enzymatic processing by MMP-2 and MMP-9 of wild-type and mutated mouse β-dystroglycan.The significance of post-translational removal of α-DG-N in early stage endometrial cancer development.Pharmacogenetics of response to neoadjuvant paclitaxel treatment for locally advanced breast cancer.Reduction of α-dystroglycan expression is correlated with poor prognosis in glioma.
P2860
Q24314890-D515BF6A-7CC6-45FA-AB97-4F6FA8DD54BFQ27319521-B06430ED-C217-43CB-8AC0-16888C6E1CB3Q30156956-2320EFF1-447A-43A5-BF78-477D284260CDQ30158028-46F61698-32F3-4DA6-858F-EA9FEA24DB3CQ30486454-5E78FB1E-C124-40EB-9118-9064436BD14BQ33284947-E9F8F304-7B4A-4DAC-BFFC-216BD07D31F2Q33774186-C3F9136F-9E21-4859-ABA1-C25DC07D7918Q33886594-CA4E4DA5-FDF8-439D-8D21-592B4AED6CE5Q34262912-E7399EFC-60CC-4DE9-B868-C878CFAEAE96Q34719164-5C6991CE-2D1C-4D9B-AA21-11C7240B2C38Q36523671-4CF5555C-7562-4C9D-B86F-EBDEB6415E13Q37296108-231536D0-7515-4E1B-A388-2C8FBD88930BQ37366097-86EDECDB-A22A-42FA-A6B3-7BE49C485E99Q37723091-99CF504E-B5AC-439E-B05D-3AA73EEB970FQ37772080-5397EDEA-B3E7-4974-9BC6-C4726174D75BQ39902339-F2A95535-EFDF-45B8-80AF-A20D3D55200AQ41820882-F0337F86-247E-49B0-93D4-FD6FBD9E680CQ42451626-F1BA27FD-0C00-45F0-A9CA-EA2CA6D2B0E2Q42482003-B8FBB063-7DB9-415E-990F-F0E25FAC763FQ42947899-D20DA11E-C54E-4292-A0E9-E4F75D0CCAE0Q42974814-9A12FF54-70F9-44B2-8514-44DE93E6AA55Q43298109-BEB275DC-821C-4454-87E2-3640C139BE1FQ45485274-DFB5FA55-2DBC-422E-9E8B-FB65FCA39AC3Q47106698-AC0A00E9-33CE-44B8-865C-CBC85D80609AQ47241273-7A82162B-FB95-4C85-8ABC-724787CEA5B1Q48595497-BA807522-AA99-4475-AABF-7A9C37DD0274
P2860
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
The dystroglycan complex: from biology to cancer.
@ast
The dystroglycan complex: from biology to cancer.
@en
type
label
The dystroglycan complex: from biology to cancer.
@ast
The dystroglycan complex: from biology to cancer.
@en
prefLabel
The dystroglycan complex: from biology to cancer.
@ast
The dystroglycan complex: from biology to cancer.
@en
P2860
P356
P1476
The dystroglycan complex: from biology to cancer.
@en
P2093
Alessandro Sgambato
Andrea Brancaccio
P2860
P304
P356
10.1002/JCP.20411
P577
2005-11-01T00:00:00Z